Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Haas Jason sold 6,461 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 15, 2026
On Jun 12, 2026, Haas Jason (Director) sold 6,461 Ligand Pharmaceuticals Incorporated shares at an average US$255.58 for US$1.65M, leaving 4,981 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 6,461 shares
- Price
- US$255.58 average (US$255.01 to US$256.08)
- Value
- US$1.65M
- Holding after
- 4,981 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Option exercise | 3,000 | US$51.56 | 10,442 | Direct |
| Jun 12, 2026 | Common Stock | Option exercise | 1,000 | US$51.56 | 11,442 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 3,000 | US$255.01 | 8,442 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 3,461 | US$256.08 | 4,981 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Haas Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Haas Jason · Aug 14, 2026
- Form 4 · Haas Jason · Jun 9, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026